on Medical Innovation & Regulatory Policy
Sun E, Jena A, Lakdawalla D, Reyes C, Philipson T, Goldman D. "The Contributions of Improved Therapy and Earlier Detection to Cancer Survival." . 2011.
Sun E, Jena A, Lakdawalla D, Reyes C, Philipson T, Goldman D. "An Economic Evaluation of the War on Cancer." Journal of Health Economics, forthcoming.. 2011.
Lakdawalla D, Sood N "Incentives to Innovate." Handbook of Pharmaceutical Economics, Oxford University Press, forthcoming.. 2011.
Karaca-Mandic P, Joyce G, Laouri M, Goldman D "Price Sensitivity and the Use of Specialty Drugs for Rheumatoid Arthritis." Health Services Research, forthcoming.. 2011.
Lakdawalla, Darius, and George Zanjani "Catastrophe Bonds, Reiunsurance, and the Optimal Collateralization of Risk Transfer." The Journal of Risk and Insurance, forthcoming.. 2011.
Lakdawalla, Darius, and Tomas Philipson. "Intellectual Property and Marketing in the Pharmaceutical Industry." Journal of Law and Economics, forthcoming. 2011.
Goldman, Dana, Darius Lakdawalla, John Romley, and Tomas Philipson. "The Benefits from Giving Makers of Conventional ‘Small Molecule’ Drugs Longer Exclusivity Over Clinical Trial Data." Health Affairs, volume 30, pp. 184-90.. 2011.
Joyce, G "Understanding Primary Nonadherence." American Journal of Pharmacy Benefits 2(2);1-2. 2010.
Goldman D, Jena A, Lakdawalla D, Malin J, Malkin J, Sun E "The Value of Specialty Oncology Drugs." Health Services Research, 45(1):115-132. 2010.
Gailey A, Lakdawalla D, Sood N "Patents, innovation, and the welfare effects of Medicare Part D." Advances in Health Economics and Health Services Research, Volume 22, pp.317-344. 2010.
Solomon M, Goldman D, Joyce G, Escarce J. "Cost sharing and the initiation of drug therapy for the chronically ill." Archives of Internal Medicine, 169(8):740-748. 2009.
Lakdawalla D, Sood N "Innovation and the Welfare Effects of Public Drug Insurance." Journal of Public Economics 93 (3-4):541-548. 2009.